An Observational Study of the Knowledge, Attitude and Practice of ADR Reporting among the Junior Doctors of Jawaharlal Nehru Institute of Medical Sciences (JNIMS), Imphal.

ABSTRACT

One of the health problems which is associated during the management of a patient with series of drugs is ADR/ADE. Therefore, the aim of the present study was to find out the activities for improving the reporting of ADRs/ADEs. The data on the KAP is collected on a pre-tested questionnaire.METHODSThis is a non-interventional cross-sectional study. The questionnaire was prepared after referring the questionnaires of previous studies. Out of 120 questionnaires distributed, only 100 questionnaires were received back. Descriptive statistics is used for analysing the data.RESULTSThe response on the questionnaire is 83.3%. Seventy-nine (79) participants knew the definition of ADR/ADE. Eighty-eight (88) participants want to report the ADRs of the marketed drugs irrespective of new or old. Seventy-five (75) participants know about PvPI. Ninety (90) participants do not consider all the OTC and Herbal drugs are safe. Seventy-two (72) participants do not know the establishment of a Pharmacovigilance centre at the Department of Pharmacology, JNIMS. Only 55.6% of the participants oblige to report the ADRs as a professional health care provider. 58% of the participants opine to conduct a regular CME program on ADR/Pharmacovigilance. 63.2% participants state that maximum ADRs are seen among dermatological, paediatric and elderly patients. 58.2% of the participants express their opinion about the occurrence of ADRs/ADEs with irrational prescription, polypharmacy, foods, drinks etc. 44% participants have the attitude of reporting ADRs/ADEs but only 10% participants perform the actual reporting with careful observations on patients’ behaviour. Most of the ADRs/ADEs are avoidable if there is good communication and reporting.CONCLUSIONSA regular awareness programme on ADR/ADE along with CME program and also online reporting facilities is necessary for promotion of reporting of the ADR/ADE. Therefore, the drug should be prescribed rationally, and polypharmacy should be avoided as much as possible.